{"disease":{"id":"sedation-in-intubated-patients","name":"Sedation in Intubated Patients","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":4,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"midazolam-hydrochloride","indication_name":"Sedation in Intubated Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"Midazolam Hydrochloride","company_name":"Takeda Pharmaceutical Company Limited","drug_phase":"marketed","molecular_target":"GABA A receptor alpha-5/beta-2/gamma-2","drug_class":"Benzodiazepine","quality_score":58,"revenue":null,"mechanism":""},{"drug_id":"midazolam","indication_name":"Sedation in Intubated Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Versed","generic_name":"midazolam","company_name":"Generic (originally Roche)","drug_phase":"marketed","molecular_target":"Multidrug resistance protein 1, Cytochrome P450 3A4, GABA A receptor alpha-3/beta-2/gamma-2","drug_class":"Benzodiazepine (short-acting)","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"diprivan","indication_name":"Sedation in Intubated Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Diprivan","company_name":"St. Antonius Hospital","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C9, Fatty-acid amide hydrolase 1, Transient receptor potential cation channel subfamily V member 4","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"propofol","indication_name":"Sedation in Intubated Patients","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diprivan","generic_name":"Propofol","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"GABA A receptors","drug_class":"General anesthetic","quality_score":10,"revenue":null,"mechanism":"Propofol produces sedative/anesthetic effects by positive modulation of inhibitory GABA function through GABA A receptors."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[{"drug_id":"propofol","guideline_body":"FDA label","recommendation":"Propofol injectable emulsion is indicated for intensive care unit (ICU) sedation of intubated, mechanically ventilated adult patients.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null},{"drug_id":"midazolam-hydrochloride","guideline_body":"FDA label","recommendation":"Midazolam injection is indicated for continuous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a critical care setting.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null},{"drug_id":"midazolam","guideline_body":"FDA label","recommendation":"Midazolam injection is indicated for continuous intravenous infusion for sedation of intubated and mechanically ventilated patients as a component of anesthesia or during treatment in a critical care setting.","line_of_therapy":"1L","evidence_grade":"A","guideline_year":null}],"source":"Drug Landscape verified database"}